Dr. Francisco Manuel Dubocq-Berdeguez, MD

Dr. Dubocq-Berdeguez practices at Instituto De Urologia Avanzada CSP in Bayamon, Puerto Rico.

Dr. Dubocq-Berdeguez's NPI, 1487699906, was assigned on June 18, 2006. Dr. Dubocq-Berdeguez holds Puerto Rico license 9736.

Dr. Dubocq-Berdeguez's primary practice is Instituto De Urologia Avanzada CSP, at 11 Santa Cruz, Bayamon, PR 00961 in Bayamon County. The practice phone is (787) 786-5305.

Dr. Dubocq-Berdeguez's primary practice is Instituto De Urologia Avanzada CSP in Bayamon, Puerto Rico. Dr. Dubocq-Berdeguez is also affiliated with Bayamón Medical Center. Dmand AI also links Dr. Dubocq-Berdeguez to 1 more hospital and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dubocq-Berdeguez practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Dubocq-Berdeguez's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Dubocq-Berdeguez's licenses on file in 2 states: Puerto Rico and New York.

CMS data shows 42 Medicare services from Dr. Dubocq-Berdeguez across 1 procedure code in 2024, all of them office visits, for 29 Medicare patients. Medicare paid $2,567 for them. Every service was in an office.

CMS counts 29 Medicare patients who saw Dr. Dubocq-Berdeguez in 2024. The largest group is 75 to 84, with 16 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dubocq-Berdeguez's median patient age at 57, with 37% women.

In 2024, Dr. Dubocq-Berdeguez wrote 2,176 Medicare Part D claims for 670 patients. 88% of them were for generic drugs. CMS names the drug for 2,074 of them, across 30 drugs with 11 or more claims each, at $115,746 in total drug cost. In 2023, CMS named 2,526 claims across 31 drugs.

Dr. Dubocq-Berdeguez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of prostate resection by Dr. Dubocq-Berdeguez, more than 67% of the clinicians it reports for that procedure.

CMS Open Payments shows 33 general payments to Dr. Dubocq-Berdeguez from 13 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Janssen Pharmaceuticals, Inc paid the most, $366.